Routine Clinical Use Of Alemtuzumab In Patients With Heavily Pretreated B-cell Chronic Lymphocytic Leukemia
Michael Fiegl, Andreas Falkner, Georg Hopfinger, Stefan Brugger, August Zabernigg, Franz Bauer, Ferdinand Haslbauer, Dita Demirtas, Peter Grossschmidt, Georg Tatzreiter, Günther Gastl, Richard Greil,